Clinical trials: Actinic Keratoses
Precancerous/Nonmalignant Condition
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a certain kind of light. When the drug is active, abnormal cells are killed.
- Trial name
- NCT00524485
- Testing
- aminolevulinic acid, laser therapy
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Roswell Park Cancer Institute
Actinic Keratosis
Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions
The purpose of this study is to find out the effectiveness of ingenol mebutate compared to cryotherapy (freezing of the tissue) for the treatment of face and scalp skin lesions.
- Trial name
- NCT01735942
- Testing
- Ingenol mebutate, cryotherapy
- Volunteers
- healthy volunteers welcome
- Sponsor
- Northwestern University
Actinic Keratoses
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
The objective of this non-interventional study (NIS) is to gain comprehensive insights into the practicability of ADL-PDT with Metvix® in patients with actinic keratoses under real-world conditions.
- Trial name
- NCT05725213
- Testing
- Metvix® 160 mg/g Creme
- Where
- Germany
- Volunteers
- 224 people
- Sponsor
- Galderma Laboratorium GmbH
Photosensitivity Disorders
Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head
Topical treatment of mild to moderate actinic keratosis located on the face and head with Solaraze® is known to be a safe and efficient treatment option.
- Trial name
- NCT00204542
- Testing
- Diclofenac
- Where
- 4 sites in Germany
- Volunteers
- 418 people
- Sponsor
- University Hospital Tuebingen
Actinic Keratosis
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis
To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions
- Trial name
- NCT03210740
- Testing
- AM001 Cream, 7.5%, Vehicle Cream
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- AmDerma
Actinic Keratosis
Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions
The purpose of this study is to evaluate the performance of two techniques to monitor the clearance of AK lesions when treated with Aldara 5% cream.
- Trial name
- NCT00294320
- Testing
- Aldara (Imiquimod), Vehicle cream
- Where
- France
- Volunteers
- 12 people
- Sponsor
- MEDA Pharma GmbH & Co. KG
Healthy, Actinic Keratosis
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.
- Trial name
- NCT01302925
- Testing
- PEP005 Gel
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Peplin
Keratosis, Actinic
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
The purpose of this study is to evaluate the potential for systemic exposure of aminolevulinic acid (ALA) when applied topically under occlusion, in a maximal use setting in patients with multiple actinic keratoses (AK) involving…
- Trial name
- NCT02281136
- Testing
- Aminolevulinic Acid (ALA), BLU-U
- Where
- 3 sites in United States
- Volunteers
- 29 people
- Sponsor
- DUSA Pharmaceuticals, Inc.
Actinic Keratoses
The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic Keratosis
Background Limited in the depth of absorption and penetration of photosensitizers, ALA-PDT treatment is not strong enough for thickening significantly AK lesions.
- Trial name
- NCT03596619
- Testing
- PBN
- Where
- 2 sites in China
- Volunteers
- 250 people
- Sponsor
- Shanghai Dermatology Hospital
Actinic Keratosis
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
This study is designed to follow up patients who have achieved complete clearance of AK lesions at the Day 57 visit having completed the PEP005-016 or PEP005-025 studies over a 12 month period to assess both recurrence of Actinic…
- Trial name
- NCT00953732
- Testing
- Lesion count
- Where
- 42 sites in United States, Australia
- Volunteers
- 117 people
- Sponsor
- Peplin
Actinic Keratosis (AK)
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
This is a phase 4, multi-centre, randomized, two group, open label, active controlled, parallel group, 17 week trial.
- Trial name
- NCT02406014
- Testing
- Ingenol Mebutate Gel, 0.015%, Diclofenac sodium gel 3%
- Where
- Germany
- Volunteers
- 502 people
- Sponsor
- LEO Pharma
Actinic Keratosis
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
The objective of this study is to evaluate the efficacy and safety of imiquimod cream versus placebo cream when used after cryosurgery in the treatment of actinic keratoses (AKs).
- Trial name
- NCT00894647
- Testing
- imiquimod cream
- Where
- 18 sites in United States, Canada
- Volunteers
- 247 people
- Sponsor
- Graceway Pharmaceuticals, LLC
Actinic Keratoses
5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities
This study evaluates the potential usefulness of photodynamic therapy with PD P 506 A in patients with actinic keratosis on the upper extremities for the first time.
- Trial name
- NCT03606122
- Testing
- PD P 506 A
- Where
- Germany
- Volunteers
- 22 people
- Sponsor
- photonamic GmbH & Co. KG
Actinic Keratosis
Twelve Month Follow-Up of CP0108
The purpose of this study is to determine the long-term safety and efficacy of Levulan PDT in subjects with multiple actinic keratosis of the upper extremities who received treatment as part of the DUSA CP0108 study.
- Trial name
- NCT02209012
- Testing
- Aminolevulinic Acid (ALA), Topical Solution Vehicle, BLU-U Blue Light Photodynamic Therapy Illuminator
- Where
- 13 sites in United States
- Volunteers
- 206 people
- Sponsor
- DUSA Pharmaceuticals, Inc.
Actinic Keratoses
A Photodynamic Therapy for Treatment of Actinic Keratoses
The purpose of this study is to compare the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs absence of treatment for actinic keratoses.
- Trial name
- NCT00558688
- Testing
- Photodynamic therapy
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Northwestern University
Actinic Keratoses
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Evaluating safety and efficacy of the use of topical retinoid with photodynamic therapy for the treatment of actinic keratoses.
- Trial name
- NCT00756288
- Testing
- Topical retinoid and blue-light therapy with photosensitizing agent, Photodynamic Therapy (PDT)
- Sponsor
- Northwestern University
Actinic Keratosis, Photo-aged Skin
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
Clinical Evaluation: Subjects having actinic keratoses and meeting Glogau Photoaging Class III or IV complete the FDA approved 3 day course of Picato® 0.015% gel as approved for the treatment of facial Actinic Keratosis.
- Trial name
- NCT03508856
- Testing
- Ingenol Mebutate (Picato®) 0.015% gel
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- Skin Laser & Surgery Specialists
Actinic Keratoses
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
In this study the impact of Oleogel-S-10 versus placebo on actinic keratoses over a treatment period of 3 months will be tested. Additionally, once and twice daily applications are tested.
- Trial name
- NCT00786994
- Testing
- Oleogel-S10 100 mg/g
- Where
- 6 sites in Germany, Greece
- Volunteers
- 165 people
- Sponsor
- Birken AG
Actinic Keratosis
A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities
The purpose of this trial is to evaluate the safety of a simultaneous treatment regimen compared to a sequential treatment regimen when two separate areas with AKs (one located on face/scalp and the other located on trunk/…
- Trial name
- NCT01787383
- Testing
- Ingenol mebutate gel 0.05 %, Ingenol mebutate gel 0.015 %
- Where
- Italy
- Volunteers
- 200 people
- Sponsor
- LEO Pharma
Photodynamic Therapy, Protoporphyrin IX
Portable Measurement of Protoporphyrin IX in the Skin
Photodynamic therapy (PDT) is increasingly used to treat superficial skin lesions, such as actinic keratosis (AK) and non-melanoma skin cancers, and has been demonstrated to be an effective and safe alternative to surgery.
- Trial name
- NCT04223570
- Testing
- Portable Apple Smart Phone Protoporphyrin IX Spectrometer Camera
- Where
- United States
- Volunteers
- 219 people, healthy volunteers welcome
- Sponsor
- Dartmouth-Hitchcock Medical Center